GIACOMELLI, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 3.436
NA - Nord America 2.218
EU - Europa 1.272
SA - Sud America 46
AF - Africa 38
OC - Oceania 36
Totale 7.046
Nazione #
US - Stati Uniti d'America 2.147
SG - Singapore 1.949
HK - Hong Kong 762
GB - Regno Unito 559
CN - Cina 468
IT - Italia 251
DE - Germania 148
IN - India 110
NL - Olanda 87
CA - Canada 64
UA - Ucraina 44
FR - Francia 37
TR - Turchia 37
AU - Australia 35
JP - Giappone 29
BR - Brasile 23
CZ - Repubblica Ceca 23
ZA - Sudafrica 20
ES - Italia 18
PT - Portogallo 17
ID - Indonesia 15
PL - Polonia 11
CL - Cile 9
EG - Egitto 9
AR - Argentina 8
AT - Austria 8
FI - Finlandia 8
IL - Israele 7
IR - Iran 7
KZ - Kazakistan 7
MX - Messico 7
DK - Danimarca 6
SA - Arabia Saudita 6
BG - Bulgaria 5
EE - Estonia 5
GR - Grecia 5
PK - Pakistan 5
SK - Slovacchia (Repubblica Slovacca) 5
CH - Svizzera 4
IE - Irlanda 4
JO - Giordania 4
RO - Romania 4
RU - Federazione Russa 4
SN - Senegal 4
BD - Bangladesh 3
KR - Corea 3
KW - Kuwait 3
LU - Lussemburgo 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
SE - Svezia 3
TH - Thailandia 3
BE - Belgio 2
CO - Colombia 2
CY - Cipro 2
EC - Ecuador 2
HU - Ungheria 2
MA - Marocco 2
PH - Filippine 2
SI - Slovenia 2
TN - Tunisia 2
VN - Vietnam 2
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 7.046
Città #
Singapore 897
Hong Kong 743
Ashburn 738
Boardman 611
London 510
Shanghai 348
Council Bluffs 114
Pune 94
San Francisco 70
Los Angeles 66
Amsterdam 62
Rome 55
Toronto 51
Washington 51
Seattle 42
West Jordan 20
Brno 19
Bari 17
Ankara 16
Tokyo 16
Santa Clara 15
Melbourne 13
Naples 11
Barcelos 10
Munich 10
New York 10
Sydney 10
Hanover 9
Milan 9
Paris 9
Canberra 8
Hangzhou 8
Jinan 8
Changsha 7
Helsinki 7
Jaguariúna 7
Frankfurt am Main 6
Guangzhou 6
Secaucus 6
Warsaw 6
Andover 5
Berlin 5
Bratislava 5
Cairo 5
Central 5
Madrid 5
Oklahoma City 5
St Louis 5
Vienna 5
Amman 4
Athens 4
Beijing 4
Bengaluru 4
Bologna 4
Dakar 4
Dublin 4
Haikou 4
Kongens Lyngby 4
Manchester 4
Markham 4
Montreal 4
Newark 4
Noicattaro 4
Nuremberg 4
Olomouc 4
Salerno 4
State College 4
Aberdeen 3
Almaty 3
Bangkok 3
Belgrade 3
Birmingham 3
Brisbane 3
Buenos Aires 3
Buffalo 3
Centurion 3
Charlotte 3
Chicago 3
Dhaka 3
Doha 3
Fiume Veneto 3
Gorle 3
Haifa 3
Kuwait City 3
Luxembourg 3
Machico 3
Muscat 3
Ottawa 3
Riyadh 3
San Giuseppe Vesuviano 3
Sofia 3
Solihull 3
Stillwater 3
São Paulo 3
Tel Aviv 3
Verona 3
West Lafayette 3
Alzano Lombardo 2
Anantapur 2
Ann Arbor 2
Totale 4.928
Nome #
------- 58
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 56
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 54
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 42
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 41
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 40
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 34
The Vessels Contribute to Fibrosis in Systemic Sclerosis 34
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 33
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 33
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 33
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 32
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 31
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 31
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 30
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 30
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 29
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 29
A comprehensive review on adult onset Still's disease 29
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 29
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 27
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 26
Development and implementation of the AIDA International Registry for patients with Behçet's disease 25
The economic burden of fibromyalgia: A systematic literature review 24
Vitamin D and systemic lupus erythematosus - The hype and the hope 24
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 24
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 24
Adult-onset Still's disease with elderly onset: results from a multicentre study 23
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 23
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 23
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 22
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy 21
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 21
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 21
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 21
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 21
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 21
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 20
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 20
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 20
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 20
Recenti acquisizioni e orientamenti nel laboratorio di immunologia 20
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 20
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 19
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 19
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 19
Interleukin-9 and T helper type 9 cells in rheumatic diseases 19
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 19
Neoplasie e sistema immune 19
Cardiovascular disease in primary sjögren’s syndrome 19
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 19
Il Laboratorio nelle malattie autoimmuni sistemiche 19
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 19
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 19
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 19
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 19
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 19
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study 18
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 18
Imbalance of immune functions in progressive systemic sclerosis patients 18
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 18
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 18
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 18
Drug interaction between cyclosporin A and nizatidine in Sprague-Dawley rats. 18
Response to Interleukin-1 Inhibitors in 140 Italian Patients With Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 18
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 18
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 18
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 18
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 18
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 18
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 18
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 17
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis 17
l'immunoterapia dei tumori 17
Potential of stem cells in the treatment of rheumatic disease 17
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 17
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 17
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 17
Polyclonal B lymphocyte activation in progressive systemic sclerosis. 17
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 17
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 17
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 17
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 17
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 17
Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database 16
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 16
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease 16
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 16
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 16
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 16
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 16
Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets 16
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 16
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study 16
Immunomodulating activity of famotidine and nizatidine. 16
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 16
The effect of non–TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis 16
Vascular complications of scleroderma 16
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 16
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 16
Totale 2.234
Categoria #
all - tutte 149.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/20254.432 230 179 617 113 109 364 242 64 1.422 1.088 4 0
Totale 7.184